Literature DB >> 29688914

Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies.

Davide Papola1,2, Giovanni Ostuzzi1, Lehana Thabane2, Gordon Guyatt2, Corrado Barbui1.   

Abstract

To investigate the extent to which exposure to first-generation and second-generation antipsychotics (APs) is associated with an increased risk of fractures, with a particular focus on hip fractures, and to ascertain the risk associated with exposure to individual drugs. We included observational studies that reported data on fractures in individuals exposed to APs compared with unexposed individuals or individuals with previous exposure. We extracted information on study design, source of data, population characteristics, outcomes of interest, matching and confounding factors, and used a modified version of the Newcastle-Ottawa Scale to judge study risk of bias. We pooled adjusted estimates of relative effects to generate pooled odds ratios (ORs) and their 95% confidence interval (CI) using a random-effects model. We rated the quality of evidence using the GRADE approach. Of 36 observational studies, 29 proved to have a low risk of bias and seven were found to have a high risk of bias. The risk of hip fracture (OR: 1.57, 95% CI: 1.42-1.74, low quality of evidence) and of any fracture (OR: 1.17, 95% CI: 1.04-1.31, very low quality of evidence) increased with exposure to APs, with similar increases in risk in the first generation and second generation. The risk was similar among different diagnostic categories. The few studies that provided data were insufficient to allow inferences on individual drugs. AP exposure in unselected populations was associated with a 57% increase in the risk of hip fractures and a 17% increase in the risk of any fractures. Between-study heterogeneity limits the confidence in this estimate.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29688914     DOI: 10.1097/YIC.0000000000000221

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  7 in total

1.  Safety of psychotropic medicines: looking beyond randomised evidence.

Authors:  C Barbui; S B Patten
Journal:  Epidemiol Psychiatr Sci       Date:  2018-07-13       Impact factor: 6.892

Review 2.  The association between video-based assessment of intraoperative technical performance and patient outcomes: a systematic review.

Authors:  Saba Balvardi; Anitha Kammili; Melissa Hanson; Carmen Mueller; Melina Vassiliou; Lawrence Lee; Kevin Schwartzman; Julio F Fiore; Liane S Feldman
Journal:  Surg Endosc       Date:  2022-05-12       Impact factor: 4.584

3.  Antipsychotic Medication in Schizophrenic Patients is Associated with Higher Risks of Developing Bone Fractures and Refractures.

Authors:  Ching-Min Kuo; Wei-Jen Liao; Chun-Che Huang; Tsuo-Hung Lan; Ching-Heng Lin; Shun-Ping Wang; Cheng-Hung Lee; Ping-Wing Lui
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-11-30       Impact factor: 2.582

4.  The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.

Authors:  Shih-Pei Shen; Yanfang Liu; Hong Qiu; Kuan-Yi Tsai; Hung-Chi Wu; Wen-Miin Liang; Meng Shu; Frank Huang-Chih Chou
Journal:  PLoS One       Date:  2019-09-05       Impact factor: 3.240

Review 5.  Hand hygiene and hand eczema: A systematic review and meta-analysis.

Authors:  Enver De Wei Loh; Yik Weng Yew
Journal:  Contact Dermatitis       Date:  2022-05-02       Impact factor: 6.419

6.  Hip, vertebral, and wrist fracture risks and schizophrenia: a nationwide longitudinal study.

Authors:  Yu-Wen Chu; Wen-Pin Chen; Albert C Yang; Shih-Jen Tsai; Li-Yu Hu; Shyh-Chyang Lee; Yao-Tung Lee; Cheng-Che Shen
Journal:  BMC Psychiatry       Date:  2022-02-01       Impact factor: 3.630

Review 7.  Lifestyle factors and hand eczema: A systematic review and meta-analysis of observational studies.

Authors:  Laura Loman; Marjolein J Brands; Anna A L Massella Patsea; Klaziena Politiek; Bernd W M Arents; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2022-04-02       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.